BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33094960)

  • 1. Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver Impairment.
    Ferrandino G; Orf I; Smith R; Calcagno M; Thind AK; Debiram-Beecham I; Williams M; Gandelman O; de Saedeleer A; Kibble G; Lydon AM; Mayhew CA; Allsworth M; Boyle B; van der Schee MP; Allison M; Hoare M; Snowdon VK
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00239. PubMed ID: 33094960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volatile Biomarkers in Breath Associated With Liver Cirrhosis - Comparisons of Pre- and Post-liver Transplant Breath Samples.
    Fernández Del Río R; O'Hara ME; Holt A; Pemberton P; Shah T; Whitehouse T; Mayhew CA
    EBioMedicine; 2015 Sep; 2(9):1243-50. PubMed ID: 26501124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel breath biomarkers identification for early detection of hepatocellular carcinoma and cirrhosis using ML tools and GCMS.
    Ain Nazir NU; Shaukat MH; Luo R; Abbas SR
    PLoS One; 2023; 18(11):e0287465. PubMed ID: 37967076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limonene in exhaled breath is elevated in hepatic encephalopathy.
    O'Hara ME; Fernández Del Río R; Holt A; Pemberton P; Shah T; Whitehouse T; Mayhew CA
    J Breath Res; 2016 Nov; 10(4):046010. PubMed ID: 27869108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function.
    Gu J; Zhang E; Liang B; Zhang Z; Chen X; Huang Z
    World J Surg Oncol; 2020 Apr; 18(1):79. PubMed ID: 32326968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The screening of volatile markers for hepatocellular carcinoma.
    Qin T; Liu H; Song Q; Song G; Wang HZ; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2247-53. PubMed ID: 20826831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study for the prediction of liver function related scores using breath biomarkers and machine learning.
    Patnaik RK; Lin YC; Agarwal A; Ho MC; Yeh JA
    Sci Rep; 2022 Feb; 12(1):2032. PubMed ID: 35132067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaled volatile organic compounds for diagnosis of hepatocellular carcinoma.
    Sukaram T; Tansawat R; Apiparakoon T; Tiyarattanachai T; Marukatat S; Rerknimitr R; Chaiteerakij R
    Sci Rep; 2022 Mar; 12(1):5326. PubMed ID: 35351916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease.
    Diaz-Sanchez A; Matilla A; Nuñez O; Rincon D; Lorente R; Lo Iacono O; Merino B; Hernando A; Campos R; Clemente G; Bañares R
    Ann Hepatol; 2013; 12(2):236-47. PubMed ID: 23396735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
    El-Serag HB; Kanwal F; Davila JA; Kramer J; Richardson P
    Gastroenterology; 2014 May; 146(5):1249-55.e1. PubMed ID: 24462733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.
    Sinha R; Lockman KA; Homer NZM; Bower E; Brinkman P; Knobel HH; Fallowfield JA; Jaap AJ; Hayes PC; Plevris JN
    JHEP Rep; 2020 Oct; 2(5):100137. PubMed ID: 32775974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning analysis of volatolomic profiles in breath can identify non-invasive biomarkers of liver disease: A pilot study.
    Thomas JN; Roopkumar J; Patel T
    PLoS One; 2021; 16(11):e0260098. PubMed ID: 34847181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
    Palmieri VO; Grattagliano I; Minerva F; Pollice S; Palasciano G; Portincasa P
    J Surg Res; 2009 Dec; 157(2):199-207. PubMed ID: 19540521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous Volatile Organic Compound (EVOC
    Ferrandino G; Ricciardi F; Murgia A; Banda I; Manhota M; Ahmed Y; Sweeney K; Nicholson-Scott L; McConville L; Gandelman O; Allsworth M; Boyle B; Smolinska A; Ginesta Frings CA; Contreras J; Asenjo-Lobos C; Barrientos V; Clavo N; Novoa A; Riviotta A; Jerez M; Méndez L
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001958
    [No Abstract]   [Full Text] [Related]  

  • 16. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis.
    Hanouneh IA; Zein NN; Cikach F; Dababneh L; Grove D; Alkhouri N; Lopez R; Dweik RA
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):516-23. PubMed ID: 24036050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
    Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
    Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging enhancement with superparamagnetic iron oxide in chronic liver disease: influence of liver dysfunction and parenchymal pathology.
    Yamashita Y; Yamamoto H; Hirai A; Yoshimatsu S; Baba Y; Takahashi M
    Abdom Imaging; 1996; 21(4):318-23. PubMed ID: 8680301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breath biomarkers of liver cirrhosis.
    Dadamio J; Van den Velde S; Laleman W; Van Hee P; Coucke W; Nevens F; Quirynen M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():17-22. PubMed ID: 22921634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FIB-4 index for assessing the prognosis of hepatocellular carcinoma in patients with Child-Pugh class A liver function.
    Ito T; Kumada T; Toyoda H; Tada T
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1311-9. PubMed ID: 25648362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.